Advancing Long-Acting PrEP in Practice: Primary Care and Pharmacy Strategies for HIV Prevention

Clinicians break down HIV PrEP, its near-99% protection, and who’s missing out—women, youth, and Southern communities in PrEP deserts.

Patients rarely ask about PrEP unless someone asks first. The faculty describe how primary care clinicians and community pharmacists can open the conversation with confidence and without judgment.

Confirming HIV-negative status before starting PrEP, and at every follow-up, protects against partial treatment and drug resistance. The faculty compare testing strategies across clinical and pharmacy settings.

A gap between perceived and actual risk, messaging that has not reached women, and long drive times to a prescriber all limit PrEP uptake. The faculty examine what sustains PrEP deserts and how to bridge them.

Every clinician can prescribe or refer for PrEP. The faculty outline the education, team structures, and community outreach that build prescriber confidence, and explain why HIV prevention still matters in the treatment era.